Vertex Pharmaceuticals (VRTX) earnings per share (EPS)

Earnings per share · fiscal 2025
$15.32

Vertex Pharmaceuticals (VRTX) reported diluted earnings per share of $15.32 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.08. Figures as of 17 Nov 2026, 19:06 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$15.32
Growth, 5 years
+8.3% a year
Highest on record
$15.32fiscal 2025
Lowest on record
-$3.77fiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vertex Pharmaceuticals earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 8.3% a year. Across the 18 fiscal years on record (2008–2025), the highest was $15.32 in fiscal 2025 and the lowest -$3.77 in fiscal 2010.

History · 18 fiscal years

Earnings per share by fiscal year

Vertex Pharmaceuticals earnings per share (EPS), year by year

Vertex Pharmaceuticals (VRTX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$15.32—
2024-$2.08 115.0% down
2023$13.89 8.3% up
2022$12.82 42.3% up
2021$9.01 12.4% down
2020$10.29 128.2% up
2019$4.51 44.3% down
2018$8.09 677.9% up
2017$1.04—
2016-$0.46—
2015-$2.31—
2014-$3.14—
2013-$1.98—
2012-$0.50 457.1% down
2011$0.14—
2010-$3.77—
2009-$3.71—
2008-$3.27—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Vertex Pharmaceuticals and comparable companies
CompanyEarnings per shareFiscal year
Pfizer PFE$1.362025
Danaher DHR$5.052025
Intuitive Surgical ISRG$7.872025
Vertex Pharmaceuticals VRTX$15.322025
Medtronic MDT$3.732026
Bristol-Myers Squibb BMY$3.462025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals earnings per share (EPS): questions and answers

What is Vertex Pharmaceuticals's diluted earnings per share?

Vertex Pharmaceuticals (VRTX) reported diluted earnings per share of $15.32 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.08.

What is the growth rate of Vertex Pharmaceuticals's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 8.3% a year.

What are the highest and lowest diluted earnings per share figures on record for Vertex Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was $15.32 in fiscal 2025 and the lowest -$3.77 in fiscal 2010.

How is Vertex Pharmaceuticals's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/VRTX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.